Search Results

There are 22205 results for: content related to: Electrocardiogram changes and arrhythmias in venlafaxine overdose

  1. Establishing bioequivalence of racemic venlafaxine formulations using stereoselective assay method: Is it necessary?


    Volume 23, Issue 10, November 2011, Pages: 948–954, Kirti Kandhwal, Surajit Dey, Shabana Nazarudheen, Simrit Reyar, Sanjeev Mishra, Nageshwar R. Thudi, Arshad H. Khuroo and Tausif Monif

    Article first published online : 26 SEP 2011, DOI: 10.1002/chir.21021

  2. Changes in cardiovascular function after venlafaxine but not pregabalin in healthy volunteers: a double-blind, placebo-controlled study of orthostatic challenge, blood pressure and heart rate

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 6, November 2013, Pages: 562–575, Alison Diaper, Ann S. Rich, Sue J. Wilson, Kevin Craig, Colin T. Dourish, Gerry R. Dawson, David J. Nutt and Jayne E. Bailey

    Article first published online : 16 AUG 2013, DOI: 10.1002/hup.2346

  3. Venlafaxine for neuropathic pain in adults

    Intervention Review

    The Cochrane Library

    Helen C Gallagher, Ruth M Gallagher, Michelle Butler, Donal J Buggy and Martin C Henman

    Published Online : 23 AUG 2015, DOI: 10.1002/14651858.CD011091.pub2

  4. The disposition of venlafaxine enantiomers in dogs, rats, and humans receiving venlafaxine


    Volume 4, Issue 2, 1992, Pages: 84–90, C. Paul Wang, Stanley R. Howell, Joann Scatina and Samuel F. Sisenwine

    Article first published online : 21 SEP 2004, DOI: 10.1002/chir.530040204

  5. Neuropharmacology of venlafaxine

    Depression and Anxiety

    Volume 12, Issue S1, 2000, Pages: 20–29, Patrick H. Roseboom and Ned H. Kalin

    Article first published online : 7 NOV 2000, DOI: 10.1002/1520-6394(2000)12:1+<20::AID-DA3>3.0.CO;2-M

  6. Venlafaxine: Discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites


    Volume 32, Issue 3, 1 June 1999, Pages: 198–211, Jean-Claude Béïque, Claude De Montigny, Pierre Blier and Guy Debonnel

    Article first published online : 29 APR 1999, DOI: 10.1002/(SICI)1098-2396(19990601)32:3<198::AID-SYN6>3.0.CO;2-2

  7. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 4, April 2001, Pages: 245–251, Thomas P. Enggaard, Niels A. Klitgaard, Lars F. Gram, Lars Arendt-Nielsen and Søren H. Sindrup

    Article first published online : 2 APR 2001, DOI: 10.1067/mcp.2001.114873

  8. Absolute Bioavailability and Electroencephalographic Effects of Conventional and Extended-Release Formulations of Venlafaxine in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 38, Issue 3, March 1998, Pages: 256–267, Dr. Alain Patat, Mr. Steven Troy, Dr. Jim Burke, Dr. Suzanne Trocherie, Dr. Philippe Danjou, Dr. Franck Le Coz, Dr. Hervé Allain and Dr. Jean-Marc Gandon

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1998.tb04423.x

  9. You have free access to this content
    Blockade of 5-Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine

    British Journal of Pharmacology

    Volume 125, Issue 3, October 1998, Pages: 526–532, Jean-Claude Béïque, Claude de Montigny, Pierre Blier and Guy Debonnel

    Article first published online : 3 FEB 2009, DOI: 10.1038/sj.bjp.0702074

  10. The treatment of depression with different formulations of venlafaxine: a comparative analysis

    Human Psychopharmacology: Clinical and Experimental

    Volume 19, Issue 1, January 2004, Pages: 9–16, James S. Olver, Graham D. Burrows and Trevor R. Norman

    Article first published online : 5 JAN 2004, DOI: 10.1002/hup.551

  11. Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks

    Journal of Biomedical Materials Research Part A

    Volume 72A, Issue 1, 1 January 2005, Pages: 107–114, Hu Yang and Stephanie T. Lopina

    Article first published online : 29 NOV 2004, DOI: 10.1002/jbm.a.30220

  12. Venlafaxine and Nefazodone, Two Pharmacologically Distinct Antidepressants

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 3, May-June 1997, Pages: 511–530, Bruce G. Augustin, Julie A. Cold and Michael W. Jann

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03060.x

  13. Venlafaxine as the ‘baby ecstasy’? Literature overview and analysis of web-based misusers′ experiences

    Human Psychopharmacology: Clinical and Experimental

    Volume 30, Issue 4, July 2015, Pages: 255–261, Giulia Francesconi, Laura Orsolini, Duccio Papanti, John M. Corkery and Fabrizio Schifano

    Article first published online : 28 JUL 2015, DOI: 10.1002/hup.2476

  14. You have free access to this content
    A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 1, February 2015, Pages: 1–6, L. A. VanderWeide, S. M. Smith and K. E. Trinkley

    Article first published online : 7 OCT 2014, DOI: 10.1111/jcpt.12216

  15. You have free access to this content
    Venlafaxine oxidation in vitro is catalysed by CYP2D6

    British Journal of Clinical Pharmacology

    Volume 41, Issue 2, February 1996, Pages: 149–156, S. V. OTTON, S. E. BALL, S. W. CHEUNG, T. INABA, R. L. RUDOLPH and E. M. SELLERS

    Article first published online : 29 OCT 2008, DOI: 10.1111/j.1365-2125.1996.tb00173.x

  16. Effect of Terbinafine and Voriconazole on the Pharmacokinetics of the Antidepressant Venlafaxine

    Clinical Pharmacology & Therapeutics

    Volume 83, Issue 2, February 2008, Pages: 342–348, V-V Hynninen, KT Olkkola, L Bertilsson, K Kurkinen, PJ Neuvonen and K Laine

    Article first published online : 8 AUG 2007, DOI: 10.1038/sj.clpt.6100311

  17. You have free access to this content
    Comparison of the effects of venlafaxine, desipramine, and paroxetine on noradrenaline- and methoxamine-evoked constriction of the dorsal hand vein

    British Journal of Clinical Pharmacology

    Volume 48, Issue 3, September 1999, Pages: 345–354, Abdelmawla, Langley, Szabadi and Bradshaw

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00031.x

  18. The Pharmacokinetics of Venlafaxine When Given in a Twice-Daily Regimen

    The Journal of Clinical Pharmacology

    Volume 35, Issue 4, April 1995, Pages: 404–409, Steven M. Troy, Vernon D. Parker, Richard J. Fruncillo and Soong T. Chiang

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1995.tb04081.x

  19. You have free access to this content
    Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997–2007

    Birth Defects Research Part A: Clinical and Molecular Teratology

    Volume 97, Issue 1, January 2013, Pages: 28–35, Kara N. D. Polen, Sonja A. Rasmussen, Tiffany Riehle-Colarusso, Jennita Reefhuis and and the National Birth Defects Prevention Study

    Article first published online : 26 DEC 2012, DOI: 10.1002/bdra.23096

  20. Dose-related effects of venlafaxine on pCREB and brain-derived neurotrophic factor (BDNF) in the hippocampus of the rat by chronic unpredictable stress

    Acta Neuropsychiatrica

    Volume 23, Issue 1, February 2011, Pages: 20–30, Jing-Jing Li, Yong-Gui Yuan, Gang Hou and Xiang-Rong Zhang

    Article first published online : 5 JAN 2011, DOI: 10.1111/j.1601-5215.2010.00512.x